Danaher Corp.

Organisation

2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701

Headquarters

58000

Employees

Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables 

Industry

Rainer Blair

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Price

Target

Danaher Corp. (DHR) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Danaher Corp. (DHR) share price will touch around $264.91 in next 12-months.

Currently 30 wall-street analysts regularly analyze the financials of Danaher Corp. on a frequent basis to provide recommendations along with target share price. 30 analysts offering 12-month price forecasts for Danaher Corp. (DHR) have a share price target of $264.91. This median of share price forecast represents a 35.8% upside from the latest price of $195.07 as on 12.03.26.

Danaher Corp. (DHR) Share Price Forecast

Home

US Stocks

Danaher Corp. (DHR)

Danaher Corp. Stock Forecast

Danaher Corp. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Danaher Corp. (DHR): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Danaher Corp.'s share price and its median forecast price. As on 12.03.26, the difference is -13.15%

Danaher Corp. Forecast and Target Price

Danaher Corp. (DHR) Share Price Forecast

Danaher Corp. (DHR) Price vs Consensus Price Target

Danaher Corp. (DHR) Share Price Forecast v/s Share Price Today

Danaher Corp. (DHR): Difference between Current Price & Median Forecasted Price

Danaher Corp. (DHR) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price